381 related articles for article (PubMed ID: 36242051)
1. Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies.
Xu J; Chen H; Qian H; Wang F; Xu Y
J Nanobiotechnology; 2022 Oct; 20(1):448. PubMed ID: 36242051
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species-responsive supramolecular deucravacitinib self-assembly polymer micelles alleviate psoriatic skin inflammation by reducing mitochondrial oxidative stress.
Yao L; Tian F; Meng Q; Guo L; Ma Z; Hu T; Liang Q; Li Z
Front Immunol; 2024; 15():1407782. PubMed ID: 38799436
[TBL] [Abstract][Full Text] [Related]
3. Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets.
Li L; Lu J; Liu J; Wu J; Zhang X; Meng Y; Wu X; Tai Z; Zhu Q; Chen Z
Front Immunol; 2023; 14():1340677. PubMed ID: 38239345
[TBL] [Abstract][Full Text] [Related]
4. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
5. Pro-oxidant status and Nrf2 levels in psoriasis vulgaris skin tissues and dimethyl fumarate-treated HaCaT cells.
Lee YJ; Bae JH; Kang SG; Cho SW; Chun DI; Nam SM; Kim CH; Nam HS; Lee SH; Lee SH; Cho MK
Arch Pharm Res; 2017 Sep; 40(9):1105-1116. PubMed ID: 28918452
[TBL] [Abstract][Full Text] [Related]
6. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
7. Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis.
Chen Y; Tai Z; Zhu C; Yu Q; Zhu Q; Chen Z
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203230
[TBL] [Abstract][Full Text] [Related]
8. Antipsoriatic drug development: challenges and new emerging therapies.
García-Pérez ME; Jean J; Pouliot R
Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):3-21. PubMed ID: 22022925
[TBL] [Abstract][Full Text] [Related]
9. ROS-sensitive calcipotriol nano-micelles prepared by methoxypolyethylene glycol (mPEG) - modified polymer for the treatment of psoriasis.
Hua Y; Chang T; Jiang K; Wang J; Cui X; Cheng M; Yan F; Song B; Wang Y
Drug Deliv; 2022 Dec; 29(1):1903-1913. PubMed ID: 35748409
[TBL] [Abstract][Full Text] [Related]
10. A multifunctional composite hydrogel as an intrinsic and extrinsic coregulator for enhanced therapeutic efficacy for psoriasis.
Xu J; Chen H; Chu Z; Li Z; Chen B; Sun J; Lai W; Ma Y; He Y; Qian H; Wang F; Xu Y
J Nanobiotechnology; 2022 Mar; 20(1):155. PubMed ID: 35331238
[TBL] [Abstract][Full Text] [Related]
11. Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models.
Jiang BW; Zhang WJ; Wang Y; Tan LP; Bao YL; Song ZB; Yu CL; Wang SY; Liu L; Li YX
Biomed Pharmacother; 2020 Jan; 121():109615. PubMed ID: 31707343
[TBL] [Abstract][Full Text] [Related]
12. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
13. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
14. Delivery and Anti-Psoriatic Effect of Silibinin-Loaded Polymeric Micelles: An Experimental Study in the Psoriatic Skin Model.
Chavoshy F; Zadeh BSM; Tamaddon AM; Anbardar MH
Curr Drug Deliv; 2020; 17(9):787-798. PubMed ID: 32703129
[TBL] [Abstract][Full Text] [Related]
15. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
[TBL] [Abstract][Full Text] [Related]
16. Role of Apoptotic-targeted Phytoconstitutent-loaded Antipsoriatic Nanobiocomposites.
Singh Patel P; Srivastava R; Panchawat S
Recent Pat Nanotechnol; 2024; 18(2):220-236. PubMed ID: 36725825
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris.
Jarocka-Karpowicz I; Biernacki M; Wroński A; Gęgotek A; Skrzydlewska E
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32121131
[TBL] [Abstract][Full Text] [Related]
18. Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management.
Kadian V; Kumar S; Saini K; Kakkar V; Rao R
Curr Drug Res Rev; 2020; 12(2):82-96. PubMed ID: 32484107
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for psoriasis in the K14-VEGF transgenic mouse model by topical transdermal delivery of interleukin-4 using ultradeformable cationic liposome.
Li J; Li X; Zhang Y; Zhou XK; Yang HS; Chen XC; Wang YS; Wei YQ; Chen LJ; Hu HZ; Liu CY
J Gene Med; 2010 Jun; 12(6):481-90. PubMed ID: 20527041
[TBL] [Abstract][Full Text] [Related]
20. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
